Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipid Lowering Agents in Diabetic Retinopathy
NCT04140201Phase 4Unknown
- Start
- Feb 2020
- Primary completion
- Jun 2020
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of simvastatin, fenofibrate, omega-3-acid triglycerides in diabetic retinopathy (DR). Status: unknown.
02
Drugs
simvastatinfenofibrateomega-3-acid triglycerides
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT04140201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04140201.